ProPublica reports, “Inspectors repeatedly found manufacturing and device quality problems with the HeartWare heart pump,” but “the FDA did not penalize the company, and patients had the device implanted on their hearts without knowing the facts.” The article says that the FDA “failed to protect…thousands of other patients whose survival depended on the HVAD, a ProPublica investigation found.”

From the Texas Trial Lawyers Association news release.